Atai Life Sciences reports Q3 results, highlighting FDA clearance for DMT film, upcoming MDMA trials, and a strong cash position.
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Where Today's News Shapes Tomorrow
December 6, 2024
Headlines
